-Dow Industrial futures up 87 points. -S&P 500 futures up 8 points. -Nasdaq 100 up 15 points. -Nasdaq-100 Pre-Market Indicator Up 10.90 at 1903.24. GLOBAL SENTIMENT Nikkei up 1.6% Hang Seng up 0.4% FTSE-100 up 0.1% PRE-MARKET SECTOR WATCH (+) Large cap tech: firmer (+) Chip stocks: firmer (+) Software stocks: firmer (+) Internet stocks: firmer (+,-) Drug stocks: mixed (+) Financial stocks: higher (+,-) Industrial stocks: mixed (+,-) Auto stocks: mixed (+,-) Airline stocks: mixed (+) Retail stocks: firmer UPSIDE MOVERS (+) ARST (+26.2%) confirms earlier reports of deal with HPQ (+0.4%) for $43.50 a share. (+) DTG (+6.1%) gets revised $50 offer from Hertz: WSJ. (+) CYCC (+26.7%) inks FDA agreement for SPA design for Sapacitabine trial in AML. (+) ACTU (+1.4%) upgraded. (+) INCY (+3%) gets FDA special protocol assessment in Polycythemia Vera. (+) OPEN (+4%) upgraded. (+) INO (+14%) jumps on positive study data. (+) MA (+0.5%) upgraded. (+) V (+0.4%) upgraded. (+) AONE (+9.7%) opens lithium battery plant. (+) XRX (+7%) gains on favorable Barron's cover piece. (+) GTSI (+33%) jumps as Eyak stands by $7 per share offer. (+) GERN (+2%) get license for deriving cartilage from human embryonic stem cells. (+) NOK (+2%) gets upgrade, mobile solutions head to leave. (+) SNTS (+6.3%) adds drug candidates to pipeline. DOWNSIDE MOVERS (-) SGEN (-0.2%) says lintuzumab trial does not meet primary endpoint. (-) INT (-1.6%) selling shares. (-) AZO (-1%) downgraded. MARKET DIRECTION U.S. stocks and commodities look to join their global counterparts in robust trade Monday, lifted by upbeat Chinese economic data and new global rules on bank capital requirements.